You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
15 September 2025 - Biopharmaceutical company Forte Biosciences Inc (NASDAQ: FBRX) on Monday reported additional data from its Phase 1b trial of FB102 in celiac disease, presented at the Tampere Celiac Disease Symposium in Finland on 12 September 202...
15 September 2025 - Biotechnology company Kodiak Sciences Inc (Nasdaq: KOD) announced on Monday that new data from its Phase 1b APEX study of KSI-101 showed rapid and clinically meaningful vision gains in patients with macular edema secondary to infl...
15 September 2025 - Precision medicine diagnostics company Renalytix plc (LSE: RENX) (OTCQB: RNLXY) announced on Monday that it has entered a definitive collaboration agreement with technology company Tempus AI Inc (NASDAQ: TEM) to expand access to i...
15 September 2025 - LakeShore Biopharma Co, Ltd (Nasdaq: LSB), a China-based global biopharmaceutical company that is involved in discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infecti...
11 September 2025 - Citius Oncology Inc (Nasdaq:CTOR), the oncology-focused subsidiary of biopharmaceutical company Citius Pharmaceuticals Inc (Nasdaq:CTXR), announced on Wednesday the closing of its previously announced registered direct offering an...
11 September 2025 - Swedish clinical-stage pharmaceutical company Diamyd Medical (STO: DMYD-B) announced on Wednesday that the Eurasian Patent Office will grant a patent covering the use of insulin-based antigens for the treatment of type 1 diabetes ...
10 September 2025 - Danish pharmaceutical company Novo Nordisk A/S (CPH:NOVO-B) (NYSE:NVO) on Wednesday announced plans reduce its global workforce by approximately 9,000 of 78,400 positions, including around 5,000 in Denmark.This move is part of a c...